Search Results 11-20 of 15325 for Alirocumab
Antisense oligonucleotide to ApoB (mipomersen); Microsomal triglyceride transfer protein (lomitapide); Monoclonal antibodies to PCSK9 (alirocumab, evolocumab).
Alirocumab (Praluent) Evolocumab (Repatha), Decrease LDL ; usually reserved for people who have a genetic condition that causes very high LDL levels or ...
The purpose of this study is to evaluate the safety of alisertib and its effect, bad and/or good, on acute megakaryoblastic leukemia (AMKL) or myelofibrosis (MF) ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Two additional options — evolocumab and alirocumab — are available for patients who have a family history of high cholesterol or existing atherosclerotic ...
This randomized phase II trial studies how well pazopanib hydrochloride with or without ascorbic acid work in treating patients with kidney cancer that has ...
Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...
The purpose of this study is to determine whether an investigational immuno-therapy, cabiralizumab in combination with nivolumab, with or without chemotherapy, ...
Efficacy and Safety of Treatment With Alpelisib Plus Endocrine Therapy in Patients With HR+, HER2-negative aBC, With PIK3CA Mutations, Whose Disease Has ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.